GlassScriptPhysician profile
Amanda Wood
NPI 1114330420
$1,847.63
in general payments reported to CMS, 2019-2025
24 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.69 · 2021: $338 · 2022: $381 · 2023: $383 · 2024: $398 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $360.21 | 2022-2025 | |
| Glaxosmithkline, LLC. | $270.68 | 2021-2023 | Trelegy Ellipta |
| Abbvie INC. | $251.90 | 2021-2025 | Qulipta |
| Lilly USA, LLC | $195.10 | 2021-2024 | Jardiance, Zepbound, Emgality |
| Amgen INC. | $135.63 | 2023-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $131.38 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $70.17 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Astellas Pharma US INC | $57.26 | 2020-2022 | |
| Myriad Women'S Health, INC. | $52.68 | 2023 | Myrisk |
| Exeltis, USA INC. | $51.24 | 2021-2024 | Slynd |
| Phathom Pharmaceuticals, INC. | $31.56 | 2023-2025 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $27.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.05 | 2023 | Trulance, Xifaxan |
| Mylan Pharmaceuticals INC. | $24.18 | 2022 | |
| Merck Sharp & Dohme LLC | $23.65 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $18.34 | 2025 | Heplisav-B |
| Biohaven Pharmaceutical Holding Company LTD. | $18.10 | 2022 | |
| Exact Sciences Corporation | $15.30 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.28 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.13 | 2022 | |
| Gilead Sciences, INC. | $15.03 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.71 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.17 | 2024 | |
| Genentech USA, INC. | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.